CreAgri’s HIDROX® Receives the NBT Award for Outstanding Application in Health Management at Vitafoods Europe.

GENEVA, May 12, 2011 /PRNewswire/ — “Clear and credible,” said one judge. “An Excellent, comprehensively completed submission,” said another panelist. Overtaking many competitors, and analysts’ expectations, CreAgri’s HIDROXTM took the Nutraceutical Industry by storm on May 11, 2011 in Geneva at the Nutraceutical Business Technology Awards ceremony.

Antibacterial effects of HIDROX®

Executive Summary

  • Multiple lines of converging evidence link polyphenols, particularly hydroxytyrosol and HIDROX®, to improved clinical outcomes.
  • In human and animal studies, hydroxytyrosol and HIDROX® have been shown to induce significant therapeutic effects on the cardiovascular system, improve the quality of life of patients with osteoporosis, and reduce markers of inflammation. These findings have all been reported in peer-reviewed, internationally-recognised academic journals.
  • Hydroxytyrosol is well absorbed following oral administration, and rapidly reaches high levels in the blood.
  • Hydroxytyrosol and HIDROX® have strong safety profiles and are not associated with major adverse events. Patients receiving HIDROX® are likely to have a strong level of adherence to the supplement.

Continue reading

The Effects of Hydroxytyrosol on Longevity

Executive Summary

  • A range of studies implicate activation of the Sir T proteins in longevity and the extension of life span. Resveratrol affects the Sir T proteins and it is considered to have effects on longevity.
  • An important animal study has now identified hydroxytyrosol as an important natural product which leads to greater effects on key longevity proteins compared to resveratrol.
  • Hydroxytyrosol is more effective than resveratrol in increasing levels of longevity proteins and protecting animal tissue against injury. It significantly raises the levels of multiple longevity proteins and it leads to lower levels of cell death compared to resveratrol.
  • Combined with its other demonstrated effects in published animal and human studies, including its powerful antioxidant, anti inflammatory, cardioprotective, and anti bacterial effects, hydroxytyrosol has emerged as a powerful natural product with multiple beneficial effects in animals and humans. Furthermore, hydroxytyrosol has an exceptionally strong safety profile that has been verified by the FDA.

Continue reading

Profile of HIDROX®

Executive Summary

  • Multiple lines of converging evidence link polyphenols, particularly hydroxytyrosol and HIDROX®, to improved clinical outcomes.
  • In human and animal studies, hydroxytyrosol and HIDROX® have been shown to induce significant therapeutic effects on the cardiovascular system, improve the quality of life of patients with osteoporosis, and reduce markers of inflammation. These findings have all been reported in peer-reviewed, internationally-recognised academic journals.
  • Hydroxytyrosol is well absorbed following oral administration, and rapidly reaches high levels in the blood.
  • Hydroxytyrosol and HIDROX® have strong safety profiles and are not associated with major adverse events. Patients receiving HIDROX® are likely to have a strong level of adherence to the supplement.

Continue reading

An open Letter To All OLIVENOL™ Consumers from Dr. Roberto Crea

Dear OLIVENOL™ Consumers,

I am very pleased to inform you that OLIVENOL™ plus+ is now readily available in your pharmacies and clinics!

We regret the sudden interruption in supply which may have caused some frustration and discomfort to the thousands of loyal consumers.

To those of you whose quality of life were affected, I share your pain. I am aware that joint inflammation and aches, eczema, dermatitis, psoriasis and overall immune health are indications that require uninterrupted adjuvant treatment.

Continue reading